Eyecare

Follow

A Seeking Alpha analyst has reaffirmed a buy rating on Alcon (ALC) stock, highlighting its eyecare portfolio amid the abandoned acquisition of STAAR Surgical. The assessment points to resilience against market shocks and positive earnings forecasts for FY26.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline